Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Daiichi Sankyo
Chubb
Medtronic
Queensland Health
Cipla
Colorcon
McKinsey

Generated: July 15, 2018

DrugPatentWatch Database Preview

Icodextrin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for icodextrin and what is the scope of icodextrin patent protection?

Icodextrin
is the generic ingredient in one branded drug marketed by Baxter Hlthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Icodextrin has fourteen patent family members in nine countries.

There is one drug master file entry for icodextrin. One supplier is listed for this compound.
Summary for icodextrin
Synonyms for icodextrin
1-(2,6-Dichlorobenzylideneamino)guanidine
2-[(2,6-dichlorophenyl)methylideneamino]guanidine
2,6-dichlorobenzaldehyde guanylhydrazone
5051-62-7
AC1L1G45
AKOS017264577
CAS-5051-62-7
CHEMBL1313657
CTK4H1147
D02YCH
DB-051784
DB00629
DivK1c_000010
DSSTox_CID_25666
DSSTox_GSID_45666
DSSTox_RID_81042
DTXSID6045666
Extraneal
FT-0635524
HMS2233D12
HMS3370A17
Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, (E)-
KBio1_000010
KBio2_001323
KBio2_003891
KBio2_006459
KBio3_001310
KBioGR_000974
KBioSS_001323
MCULE-4615358259
MRF-0000008
N-(2,6-dichlorobenzylidene)-N'-amidino hydrazine
NCGC00024846-03
NCGC00024846-08
NINDS_000010
Prestwick0_000096
Prestwick1_000096
SPBio_001248
SPBio_001991
Spectrum_000843
Spectrum2_001114
Spectrum3_000445
Spectrum4_000567
SR-01000721838
SR-01000721838-5
Tox21_110932
Tox21_110932_1
WDZVGELJXXEGPV-UHFFFAOYSA-N
ZINC242701441

US Patents and Regulatory Information for icodextrin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for icodextrin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
US Army
Colorcon
Covington
Baxter
Boehringer Ingelheim
Chinese Patent Office
Healthtrust
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.